Cyclophosphamide Injection, Solution
NDC Package 68275-222-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cyclophosphamide injection is cyclophosphamide is used to treat various types of cancer. This formulation utilizes a injection, solution delivery system. Marketed by Ever Pharma Jena Gmbh, this product is identified by NDC 68275-222 and is authorized under FDA application ANDA216783.

Identification & Billing

NDC Package Code
68275-222-05
Package Description
1 VIAL, GLASS in 1 CARTON / 5 mL in 1 VIAL, GLASS (68275-222-07)
Product Code
68275-222
11-Digit Billing Format
68275022205

Clinical Specifications

Proprietary Name
Cyclophosphamide
Non-Proprietary Name
Cyclophosphamide
Substance Name
Cyclophosphamide
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CYCLOPHOSPHAMIDE 200 mg/mL
Usage Information
Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.

Regulatory & Marketing

Labeler Name
Ever Pharma Jena Gmbh
Product Type
Human Prescription Drug
FDA Application #
ANDA216783
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68275-222-05 identifies a specific commercial package of 1 vial, glass in 1 carton / 5 ml in 1 vial, glass (68275-222-07) of Cyclophosphamide, a human prescription drug labeled by Ever Pharma Jena Gmbh. This injection, solution is formulated for intravenous use and contains cyclophosphamide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ever Pharma Jena Gmbh on August 01, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked.

How is this Ever Pharma Jena Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68275022205. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68275-222-05
11-Digit CMS (5-4-2)
68275-0222-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.